Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers - Wikidata - awgldk - TriplyDB

Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers

Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers

http://www.wikidata.org/entity/Q33942612

about

The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials Vitamin D supplementation for prevention of cancer in adults Vitamin D, Essential Minerals, and Toxic Elements: Exploring Interactions between Nutrients and Toxicants in Clinical Medicine Epidemiology and Inherited Predisposition for Sporadic Pancreatic Adenocarcinoma Is dietary fat, vitamin D, or folate associated with pancreatic cancer?The complexities of epidemiology and prevention of gastrointestinal cancers A stochastic chemical dynamic approach to correlate autoimmunity and optimal vitamin-D range Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control study High risk factors of pancreatic carcinoma.The consequences for human health of stratospheric ozone depletion in association with other environmental factors.The human health effects of ozone depletion and interactions with climate change.Murine Pancreatic Acinar Cell Carcinoma Growth Kinetics Are Independent of Dietary Vitamin D Deficiency or Supplementation.Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.Vitamin D for Prevention and Treatment of Colorectal Cancer: What is the Evidence?Prospective study of ultraviolet radiation exposure and risk of cancer in the United States Obesity and cancer: the role of vitamin D Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006)Serum vitamin D and risk of bladder cancer Vitamin D and GI cancers: shedding some light on dark diseases Vitamin D, calcium, and retinol intake, and pancreatic cancer in a population-based case-control study in the San Francisco Bay area.The vitamin D system is deregulated in pancreatic diseases Mortality rates across 25-hydroxyvitamin D (25[OH]D) levels among adults with and without estimated glomerular filtration rate <60 ml/min/1.73 m2: the third national health and nutrition examination survey.Role of vitamin d in the prevention of pancreatic cancer.VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,0 Risk factors for pancreatic cancer: a summary review of meta-analytical studies.Rediscovering vitamin D Genetic variants in vitamin d pathway genes and risk of pancreas cancer; results from a population-based case-control study in ontario, Canada.Vitamin D and subsequent all-age and premature mortality: a systematic review.Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Serum 25-hydroxyvitamin D and risks of colon and rectal cancer in Finnish men.Serum 25-hydroxyvitamin D and risk of oropharynx and larynx cancers in Finnish men.Vitamin D status is not related to development of atrial fibrillation in the community.Vitamin D metabolic pathway genes and pancreatic cancer risk.Vitamin D and cardiovascular disease and cancer: not too much and not too little? The need for clinical trials Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study.Can vitamin D metabolite measurements facilitate a "treat-to-target" paradigm to guide vitamin D supplementation?Changing Incidence of Serum 25-Hydroxyvitamin D Values Above 50 ng/mL: A 10-Year Population-Based Study.

P2860

Q22306208-79596990-804F-4627-B1C1-5551610B16A0 Q22306552-66629691-6CFD-47BF-B65C-0D450FD2D3C7 Q24193850-A13837A8-1A1E-4FD0-86A5-2B1F6F7B0130 Q26783001-6B6240F5-1201-403E-BBAB-AE2AE13E401E Q26801418-93514803-FBD5-4132-9DFA-0789BB85AE1F Q26851126-B4D2E339-D499-4570-9CE8-57005CF60FCD Q26865429-4EAE71A7-D45B-4F47-B57A-255E03691526 Q28540144-762AF18C-E12E-423D-8354-F3899E78318C Q28743755-7BCBB3CA-E27B-48F2-8C21-54591CD17351 Q30249161-822A5B12-69F1-41EE-95AF-24C3D77EC76A Q30868560-6FF7E485-7F11-4480-82D4-EC21E7A635F9 Q33799335-F7E51C13-4931-428C-9349-A2CAB5716556 Q33845341-A92BDFDD-5863-4B3A-9AD2-2A4B2539FB40 Q33942581-AAA6EEDF-5CEA-4FA4-A03A-7C8F7494E9CC Q33942605-324C484C-FF5D-4AA3-88ED-B5B9E28C49DF Q33942618-3E470432-F38B-42C3-8F11-5241EFD14B50 Q34155562-6BBFC90C-40E8-4E09-B4E1-F4F6822BB9B0 Q34271258-166F745E-E1A2-41B4-BA1F-1FF55D99C63E Q34278744-9F8EE117-02B8-4D82-BF9B-BAECA2BB5EC4 Q34281077-0FDFC338-AE1C-4C8C-9348-68C8311CF128 Q34316447-35241BEB-F083-4D83-B3C7-3D2C9878DD93 Q34357880-B960FD9F-5C59-47E3-AB20-474E32F97EDF Q34407301-471ED58C-E42F-4FA1-95FA-A885FFBE5CFA Q34440700-6070CB19-4E51-41BE-A4E7-F70CFDEF874C Q34462171-E596D65D-B13F-4E95-A1E4-2B6CA8A5CC65 Q34512748-A8DBA959-BD1A-40EC-B4B6-9F4204EAFDF6 Q34517376-3EC8E524-DBF2-4CFC-8D6B-1431372EA1E7 Q34667061-E26607A0-2873-4BF1-B36D-589146678C34 Q34736323-35506C9D-B045-460C-89DA-9ED9FD194A5F Q34795962-EFA9263B-C30C-48F5-BCC3-EB8EF353ECCF Q34863028-A5A194DE-96D7-49C4-8491-58F0048373A6 Q34898979-F690BF6C-D772-4E62-AB31-D2BB48C4AE9A Q35017919-5F42D33F-BAA7-4044-98B4-43DBD8D8B52F Q35036628-3B6BD877-B314-4463-8A6B-53E3FCC9C1C4 Q35207725-0BFFFEBB-0BB8-4846-8DC4-954327AA34EE Q35208726-ADED43A8-AF4E-4887-A2DC-C7ABCEDA6275 Q35229958-4EDFC648-FAE7-410F-A01F-0C1FAAD68CF7 Q35286318-10100403-E745-420A-B817-EB7370413F96 Q35546413-6311F72B-4494-494E-8253-E8A788B83414 Q35621943-6CD41E5E-ABFA-4429-B8EF-98877291137E

P2860

Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers

http://www.wikidata.org/entity/Q33942612

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Circulating 25-hydroxyvitamin ...... oling Project of Rarer Cancers

@ast

Circulating 25-hydroxyvitamin ...... oling Project of Rarer Cancers

@en

type

label

Circulating 25-hydroxyvitamin ...... oling Project of Rarer Cancers

@ast

Circulating 25-hydroxyvitamin ...... oling Project of Rarer Cancers

@en

prefLabel

Circulating 25-hydroxyvitamin ...... oling Project of Rarer Cancers

@ast

Circulating 25-hydroxyvitamin ...... oling Project of Rarer Cancers

@en

P1433

Q33942612-5B356D0A-8B4F-4143-A3F8-EC1F1B63D97E

P1476

Q33942612-5C8D9FFD-CAC3-4448-9A83-1085667630DF

P2093

Q33942612-0D03A7D5-5A66-4303-884C-FD9057BE02F0

Q33942612-150E057B-440C-431D-B878-2836E6583C59

Q33942612-1FC98DEB-EDFF-4F21-8336-C224D75F0730

Q33942612-3716F21C-5597-416D-9795-49EDCE313200

Q33942612-3F30590D-9973-44CC-BC70-3C113D8DE9D3

Q33942612-5E28018E-132C-45F1-9E60-73E24E6868D6

Q33942612-601CAF13-F50E-4AE5-ABA8-EFC3119EB00D

Q33942612-7386EFD1-2C5A-4FF5-8083-27438CC93350

Q33942612-A3884339-1DD1-4E5A-B4AC-5340669ED9AF

Q33942612-A4C262E0-1ACF-46AE-8FD6-C3B9811C26F5

P2860

Q33942612-074B8402-0598-441D-8C0D-0329DE4AA50D

Q33942612-07A0FB0C-4084-45C1-8775-852807D8BA99

Q33942612-13E4F460-4B71-4C0D-AB1C-729DB566B353

Q33942612-1EBE6508-9C59-49CB-A01E-1852B93CAE3A

Q33942612-210142A7-680B-45FD-9BAD-841538FD2FA0

Q33942612-26039209-D0A6-4B43-A7F3-9F7F52121D6A

Q33942612-3CFA17FB-C6D6-4EB8-8FA3-E78130B7221F

Q33942612-40D67515-10C2-4A14-A19A-D4D0011E7A06

Q33942612-455947D7-3D7E-43AA-83C4-A9640D66A766

Q33942612-50708F8F-DEE8-4059-99D5-5D02FF7C7638

P304

Q33942612-DFA3F803-E574-4AA6-9E15-C4D3237D6397

P31

Q33942612-1D4C1C07-1BDC-457C-BDC7-06B7DCBA72DC

P356

Q33942612-A1C6FD26-6DEC-4D67-A6AB-0186ECCC50F1

P407

Q33942612-67CB796C-63CE-4D3B-B754-836ED5B0BBCC

P433

Q33942612-46D9B2D1-FAEA-4698-AA7A-2F36B4F3DA33

P478

Q33942612-17D56B1F-5004-4C33-8748-93511637C5C7

P50

Q33942612-0272A4EC-4056-4D29-936C-C13F258F711B

Q33942612-2D9D49A8-8112-4EDE-A292-B3ABC15E3050

Q33942612-34238806-BC8E-4E39-B23A-42F42AE02A2C

Q33942612-3B47B19D-1B3D-4AB0-B3A6-D156A29D9876

Q33942612-6F262171-5865-49AF-9AA1-83D7A9815B96

Q33942612-73973B78-295C-41E5-9607-F787A3055E06

Q33942612-B6548604-8CDD-47AF-AD68-DE20ECE5064C

Q33942612-B8E961D8-AA8E-4B6F-A1FC-E2F9C0A9CC2A

Q33942612-C8AA6EF3-27C8-49C2-81E7-90F18AA24785

Q33942612-F0FB2DC7-D45D-4AB9-A573-4DFA8389A303

P577

Q33942612-505AE401-0F16-4359-B085-DC7010E94491

P5875

Q33942612-5B12397A-F181-4A27-A4DB-EA0AF5BBE359

P698

Q33942612-50FBDD6A-2D64-483F-A223-DD4A89F2A91A

P921

Q33942612-BFC06B04-DAB5-4812-9828-51CA58DD37DA

P932

Q33942612-B2554748-1BF3-45D6-8480-29991D13FAAD

P356

P1433

American Journal of Epidemiology

P1476

Circulating 25-hydroxyvitamin ...... oling Project of Rarer Cancers

@en

P2093

Alan A Arslan

http://www.w3.org/2001/XMLSchema#string

Alpa V Patel

http://www.w3.org/2001/XMLSchema#string

Chinonye Harvey

http://www.w3.org/2001/XMLSchema#string

Dai Qi

http://www.w3.org/2001/XMLSchema#string

Eric J Jacobs

http://www.w3.org/2001/XMLSchema#string

Kai Yu

http://www.w3.org/2001/XMLSchema#string

Karen Koenig

http://www.w3.org/2001/XMLSchema#string

Kathy J Helzlsouer

http://www.w3.org/2001/XMLSchema#string

Kirk Snyder

http://www.w3.org/2001/XMLSchema#string

Laurence N Kolonel

http://www.w3.org/2001/XMLSchema#string

P2860

Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men

Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies

The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics

Reproducibility studies and interlaboratory concordance for androgen assays in female plasma

Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase.

Solar ultraviolet-B exposure and cancer incidence and mortality in the United States, 1993-2002.

Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis.

The role of insulin-like growth factor I components in the regulation of vitamin D.

P304

81-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/AJE/KWQ120

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

172

http://www.w3.org/2001/XMLSchema#string

P50

Demetrius Albanes

Anne Zeleniuch-Jacquotte

Loic Le Marchand

Rachael Stolzenberg-Solomon

Richard B Hayes

P577

2010-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44686813

http://www.w3.org/2001/XMLSchema#string

P698

20562185

http://www.w3.org/2001/XMLSchema#string

P921

P932

2892543

http://www.w3.org/2001/XMLSchema#string